Joaquim Peraire
Overview
Explore the profile of Joaquim Peraire including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
428
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bruguera A, Nomah D, Moreno-Fornes S, Martinez E, Negredo E, Tiraboschi J, et al.
AIDS
. 2024 Dec;
39(1):64-74.
PMID: 39639721
Objective: With HIV now a chronic condition and an aging population, understanding the evolving profiles of older people with HIV (PWH) is crucial. In this longitudinal study, we examined changes...
2.
Trujillo-Rodriguez M, Munoz-Muela E, Serna-Gallego A, Praena-Fernandez J, Perez-Gomez A, Gasca-Capote C, et al.
PLoS One
. 2024 Nov;
19(11):e0314574.
PMID: 39570969
[This corrects the article DOI: 10.1371/journal.pone.0269875.].
3.
Garrido-Rodriguez V, Bulnes-Ramos A, Olivas-Martinez I, Pozo-Balado M, Alvarez-Rios A, Gutierrez F, et al.
J Microbiol Immunol Infect
. 2024 Aug;
57(6):854-867.
PMID: 39209566
Background: Persistence of a low CD4/CD8 ratio is associated with an increased morbimortality in people living with HIV (PLWH) under effective antiretroviral therapy. We aimed to explore the immunological significance...
4.
Moreno C, Izquierdo R, Alejos B, Hernando V, Perez de la Camara S, Peraire J, et al.
AIDS Patient Care STDS
. 2024 Jun;
38(7):305-314.
PMID: 38916077
We assessed the prevalence and factors associated with HIV-infected patients' interest in trying long-acting injectable antiretroviral treatment (LAI-ART) along with its expected benefits and concerns, and evaluated physicians' opinions about...
5.
Peraire J, Garcia-Pardo G, Chafino S, Sanchez A, Botero-Gallego M, Olona M, et al.
Eur J Med Res
. 2024 Apr;
29(1):223.
PMID: 38581072
Background: COVID-19 pneumonia causes hyperinflammatory response that culminates in acute respiratory syndrome (ARDS) related to increased multiorgan dysfunction and mortality risk. Antiviral-neutralizing immunoglobulins production reflect the host humoral status and...
6.
de Lazzari E, Negredo E, Domingo P, Tiraboschi J, Ribera E, Abdulghani N, et al.
J Antimicrob Chemother
. 2024 Mar;
79(5):1133-1141.
PMID: 38546974
Introduction: The DOLAM trial revealed that switching from triple antiretroviral therapy (three-drug regimen; 3DR) to dolutegravir plus lamivudine (two-drug regimen; 2DR) was virologically non-inferior to continuing 3DR after 48 weeks...
7.
Peiro O, Delgado-Cornejo J, Sanchez-Gimenez R, Del-Moral-Ronda V, Lal-Trehan N, Rocamora-Horrach M, et al.
Front Cardiovasc Med
. 2024 Mar;
11:1297824.
PMID: 38455719
Introduction: The prognostic ability of myocardial injury across different waves of the COVID-19 pandemic is not well established. The purpose of this study was to evaluate the prevalence and prognostic...
8.
Martin-Iguacel R, Moreno-Fornes S, Bruguera A, Aceiton J, Nomah D, Gonzalez-Cordon A, et al.
Clin Microbiol Infect
. 2024 Feb;
30(5):674-681.
PMID: 38342439
Objectives: To assess the effect of COVID-19 on the postacute risk of cardiovascular events (CVEs) among people with HIV (PWH). Methods: Population-based matched cohort, including all PWH ≥16 years in...
9.
Nomah D, Diaz Y, Bruguera A, Moreno-Fornes S, Aceiton J, Reyes-Uruena J, et al.
Open Forum Infect Dis
. 2024 Jan;
11(1):ofad693.
PMID: 38221982
Background: Coronavirus disease 2019 (COVID-19) disproportionately affects migrants and ethnic minorities, including those with human immunodeficiency virus (HIV). Comprehensive studies are needed to understand the impact and risk factors. Methods:...
10.
Vinuela L, De Salazar A, Fuentes A, Serrano-Conde E, Falces-Romero I, Pinto A, et al.
J Med Virol
. 2023 Dec;
95(12):e29287.
PMID: 38084763
To evaluate the prevalence of transmitted drug resistance (TDR) to nucleoside and nonnucleoside reverse transcriptase inhibitors (NRTI, NNRTI), protease inhibitors (PI), and integrase strand transfer inhibitors (INSTI) in Spain during...